These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11773615)

  • 1. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
    Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.
    Dios A; Mitchell RA; Aljabari B; Lubetsky J; O'Connor K; Liao H; Senter PD; Manogue KR; Lolis E; Metz C; Bucala R; Callaway DJ; Al-Abed Y
    J Med Chem; 2002 Jun; 45(12):2410-6. PubMed ID: 12036350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
    Crichlow GV; Lubetsky JB; Leng L; Bucala R; Lolis EJ
    Biochemistry; 2009 Jan; 48(1):132-9. PubMed ID: 19090677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
    Garai J; Lóránd T
    Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
    Orita M; Yamamoto S; Katayama N; Fujita S
    Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
    El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
    Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
    Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
    Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human single-chain variable fragment antibody inhibits macrophage migration inhibitory factor tautomerase activity.
    Tarasuk M; Poungpair O; Ungsupravate D; Bangphoomi K; Chaicumpa W; Yenchitsomanus PT
    Int J Mol Med; 2014 Mar; 33(3):515-22. PubMed ID: 24424397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
    Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
    Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.
    Fingerle-Rowson G; Kaleswarapu DR; Schlander C; Kabgani N; Brocks T; Reinart N; Busch R; Schütz A; Lue H; Du X; Liu A; Xiong H; Chen Y; Nemajerova A; Hallek M; Bernhagen J; Leng L; Bucala R
    Mol Cell Biol; 2009 Apr; 29(7):1922-32. PubMed ID: 19188446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
    Mawhinney L; Armstrong ME; O' Reilly C; Bucala R; Leng L; Fingerle-Rowson G; Fayne D; Keane MP; Tynan A; Maher L; Cooke G; Lloyd D; Conroy H; Donnelly SC
    Mol Med; 2015 Apr; 20(1):729-35. PubMed ID: 25826675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.
    Sparkes A; De Baetselier P; Brys L; Cabrito I; Sterckx YG; Schoonooghe S; Muyldermans S; Raes G; Bucala R; Vanlandschoot P; Van Ginderachter JA; Stijlemans B
    FASEB J; 2018 Jun; 32(6):3411-3422. PubMed ID: 29401625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor.
    Ouertatani-Sakouhi H; El-Turk F; Fauvet B; Roger T; Le Roy D; Karpinar DP; Leng L; Bucala R; Zweckstetter M; Calandra T; Lashuel HA
    Biochemistry; 2009 Oct; 48(41):9858-70. PubMed ID: 19737008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
    Garai J; Lóránd T; Molnár V
    Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
    Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
    J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
    Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
    Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.
    Bloom J; Metz C; Nalawade S; Casabar J; Cheng KF; He M; Sherry B; Coleman T; Forsthuber T; Al-Abed Y
    J Biol Chem; 2016 Dec; 291(51):26502-26514. PubMed ID: 27793992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
    Spencer ES; Dale EJ; Gommans AL; Rutledge MT; Vo CT; Nakatani Y; Gamble AB; Smith RA; Wilbanks SM; Hampton MB; Tyndall JD
    Eur J Med Chem; 2015 Mar; 93():501-10. PubMed ID: 25743213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.
    Ouertatani-Sakouhi H; El-Turk F; Fauvet B; Cho MK; Pinar Karpinar D; Le Roy D; Dewor M; Roger T; Bernhagen J; Calandra T; Zweckstetter M; Lashuel HA
    J Biol Chem; 2010 Aug; 285(34):26581-98. PubMed ID: 20516071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.
    Bendrat K; Al-Abed Y; Callaway DJ; Peng T; Calandra T; Metz CN; Bucala R
    Biochemistry; 1997 Dec; 36(49):15356-62. PubMed ID: 9398265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.